MycoMed Technologies, LLC
1812 Ashland Avenue, FastForward Bldg., Ste G25-U
Baltimore MD 21205
MycoMed is focused on the development and commercialization of diagnostic tests and treatments for fungal infections. Over the past decade there has been a surge in fungal lung infections. The companyâ€™s mission is to assist clinicians in the early detection of infections so as to elicit early treatment intervention to improve patient outcomes. MycoMedâ€™s lead product is a direct antigen test for the detection of Aspergillus infection.
Powered By GrowthZone